Back to top
more

HealthEquity (HQY)

(Delayed Data from NSDQ)

$98.82 USD

98.82
666,765

+1.62 (1.67%)

Updated Nov 8, 2024 03:59 PM ET

After-Market: $98.64 -0.18 (-0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (145 out of 250)

Industry: Medical Services

Zacks News

Has HealthEquity (HQY) Outpaced Other Medical Stocks This Year?

Is (HQY) Outperforming Other Medical Stocks This Year?

    Here's Why Momentum Investors Will Love HealthEquity (HQY)

    Does HealthEquity (HQY) have what it takes to be a top stock pick for momentum investors? Let's find out.

      Looking for a Growth Stock? Why It is Time to Focus on HealthEquity (HQY)

      If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider HealthEquity (HQY).

        HealthEquity (HQY) Beats Q2 Earnings & Revenue Estimates

        Strong HSA Member growth boosts HealthEquity's (HQY) results in Q2. A strong guidance raises investors??? optimism.

          Can HSA Member Growth Drive HealthEquity's (HQY) Q2 Earnings?

          HealthEquity (HQY) is likely to register solid HSA member growth in the quarter to be reported.

            HealthEquity (HQY) Q2 Earnings Preview: How Are Events Shaping Up?

            HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

              SYNH or HQY: Which Is the Better Value Stock Right Now?

              SYNH vs. HQY: Which Stock Is the Better Value Option?

                CIVI or HQY: Which Is the Better Value Stock Right Now?

                CIVI vs. HQY: Which Stock Is the Better Value Option?

                  SYNH vs. HQY: Which Stock Is the Better Value Option?

                  SYNH vs. HQY: Which Stock Is the Better Value Option?

                    NovoCure Limited (NVCR) Looks Good: Stock Adds 7.9% in Session

                    NovoCure (NVCR) was a big mover last session, as the company saw its shares rise more than 7% on the day amid huge volumes.

                      Is HealthEquity (HQY) a Great Growth Stock?

                      HealthEquity (HQY) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

                        Can HealthEquity (HQY) Run Higher on Strong Earnings Estimate Revisions?

                        HealthEquity (HQY) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision in addition to having decent short-term momentum.

                          HealthEquity (HQY) Looks Good: Stock Adds 11.5% in Session

                          HealthEquity (HQY) was a big mover last session, as the company saw its shares rise more than 11% on the day amid huge volumes.

                            Medical Stocks Reporting Q4 Earnings on Feb 6: CNC, WCG, HQY

                            Medical stocks' fourth-quarter results are likely to benefit from higher membership, increase in premium, partly offset by high costs.

                              Should You Buy HealthEquity (HQY) Ahead of Earnings?

                              HealthEquity (HQY) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

                                Looking for a Growth Stock? Why It is Time to Focus on HealthEquity (HQY)

                                HealthEquity (HQY) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.

                                  ICON Public Limited (ICLR) Rises: Stock Adds 6.3% in Session

                                  ICON Public Limited Company (ICLR) shares rose over 6% in the last trading session.

                                    Why HealthEquity (HQY) Could Be an Impressive Growth Stock

                                    If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider HealthEquity (HQY).

                                      HealthEquity (HQY) Q4 Earnings and Revenues Beat Estimates

                                      HealthEquity Inc (HQY) reported earnings of 7 cents per share in the fourth quarter of 2016, higher than the Zacks Consensus Estimate of 5 cents.

                                        Brian Hamilton headshot

                                        Top 5 Medical Service Stocks to Buy

                                        The Medical sector is one of the top performing sectors for Q3 2015, and it is expected to be a top performer in Q4 2015 too.